Related Experiment Video
Updated: Nov 11, 2025

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
Published on: November 30, 2022
Side-Effects of COVID-19 on Patient Care: An INR Story
Lauren N Pearson1, Stacy A Johnson2, Dina N Greene3
1Department of Pathology, University of Utah, Salt Lake City, UT, USA.
Insights
The COVID-19 pandemic reduced International Normalized Ratio (INR) testing, particularly for outpatients. This led to more high INR results, increasing bleeding risks and highlighting the need for improved monitoring strategies.
Area of Science:
- Clinical Medicine
- Pharmacology
- Public Health
Background:
- The COVID-19 pandemic significantly disrupted patient care, affecting access to essential medical services and treatments.
- Reduced access to care may lead to suboptimal management of conditions like venous thromboembolism, potentially impacting therapies such as warfarin.
- International Normalized Ratio (INR) testing is crucial for monitoring warfarin therapy effectiveness and safety.
Purpose of the Study:
- To investigate the impact of the COVID-19 pandemic on the utilization of International Normalized Ratio (INR) testing.
- To determine changes in the percentage of high (≥3.5) and low (≤1.5) INR results during the pandemic.
- To compare INR testing patterns between inpatient and outpatient settings during the pandemic.
Main Methods:
- Retrospective analysis of INR data from 11 institutions, comparing pre-pandemic (Jan-June 2019) and pandemic (Jan-June 2020) periods.
- Evaluation of testing volumes and the proportion of supratherapeutic (≥3.5) and subtherapeutic (≤1.5) INR results.
- Stratification of data into inpatient and outpatient cohorts for comparative analysis.
Main Results:
- INR testing volumes remained stable in early 2020 but significantly decreased from March to May, returning to baseline in June.
- Outpatient INR testing experienced a more substantial decline in volume compared to inpatient testing.
- An increase in the percentage of high INR results (≥3.5) was observed at 10 of 11 sites, predominantly in the outpatient group, correlating with decreased testing volumes.
Conclusions:
- The COVID-19 pandemic adversely affected INR testing, particularly among outpatients, potentially due to reduced laboratory access and healthcare utilization.
- The observed increase in supratherapeutic INR results during the pandemic raises concerns about elevated bleeding event risks in patients on warfarin.
- Future strategies, including drive-through testing and widespread home INR monitoring, may mitigate these risks and improve patient safety.
Background:
Numerous studies have documented reduced access to patient care due to the COVID-19 pandemic, including access to diagnostic or screening tests, prescription medications, and treatment for an ongoing condition. In the context of clinical management for venous thromboembolism, this could result in suboptimal therapy with warfarin. We aimed to determine the impact of the pandemic on utilization of International Normalized Ratio (INR) testing and the percentage of high and low results.
Methods:
INR data from 11 institutions were extracted to compare testing volume and the percentage of INR results ≥3.5 and ≤1.5 between a pre-pandemic period (January-June 2019, period 1) and a portion of the COVID-19 pandemic period (January-June 2020, period 2). The analysis was performed for inpatient and outpatient cohorts.
Results:
Testing volumes showed relatively little change in January and February, followed by a significant decrease in March, April, and May, and then returned to baseline in June. Outpatient testing showed a larger percentage decrease in testing volume compared to inpatient testing. At 10 of the 11 study sites, we observed an increase in the percentage of abnormal high INR results as test volumes decreased, primarily among outpatients.
Conclusion:
The COVID-19 pandemic impacted INR testing among outpatients which may be attributable to several factors. Increased supratherapeutic INR results during the pandemic period when there was reduced laboratory utilization and access to care is concerning because of the risk of adverse bleeding events in this group of patients. This could be mitigated in the future by offering drive-through testing and/or widespread implementation of home INR monitoring.
More Related Videos
14:28Non-Invasive Monitoring of Microvascular Oxygenation and Reactive Hyperemia using Hybrid, Near-Infrared Diffuse Optical Spectroscopy for Critical Care
Published on: May 10, 2024
11:17Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Related Concept Videos
Rheumatic Heart Disease IV: Nursing Management
Cardiac Catheterization I: Pre-Procedure Overview
Endocarditis IV: Nursing Management
Myocarditis III: Medical Management
Venous Thrombosis III: Interprofessional Care
Pharmacokinetics: Drug–Food and Drug–Viral Interactions